These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 10780856

  • 1. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.
    Atkins GJ, Haynes DR, Graves SE, Evdokiou A, Hay S, Bouralexis S, Findlay DM.
    J Bone Miner Res; 2000 Apr; 15(4):640-9. PubMed ID: 10780856
    [Abstract] [Full Text] [Related]

  • 2. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.
    Takahashi N, Udagawa N, Suda T.
    Biochem Biophys Res Commun; 1999 Mar 24; 256(3):449-55. PubMed ID: 10080918
    [Abstract] [Full Text] [Related]

  • 3. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
    Ikeda T, Utsuyama M, Hirokawa K.
    J Bone Miner Res; 2001 Aug 24; 16(8):1416-25. PubMed ID: 11499864
    [Abstract] [Full Text] [Related]

  • 4. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
    Lau YS, Sabokbar A, Gibbons CL, Giele H, Athanasou N.
    Hum Pathol; 2005 Sep 24; 36(9):945-54. PubMed ID: 16153456
    [Abstract] [Full Text] [Related]

  • 5. Gene expression of osteoprotegerin and osteoclast differentiation factor in giant cell tumor.
    Hu Y, Yu S.
    Zhonghua Bing Li Xue Za Zhi; 2002 Apr 24; 31(2):128-31. PubMed ID: 12419159
    [Abstract] [Full Text] [Related]

  • 6. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S.
    Arthritis Rheum; 2000 Feb 24; 43(2):259-69. PubMed ID: 10693864
    [Abstract] [Full Text] [Related]

  • 7. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T.
    J Bone Miner Res; 2000 Sep 24; 15(9):1766-75. PubMed ID: 10976996
    [Abstract] [Full Text] [Related]

  • 8. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.
    J Bone Miner Res; 2000 Aug 24; 15(8):1459-66. PubMed ID: 10934644
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.
    Sordillo EM, Pearse RN.
    Cancer; 2003 Feb 01; 97(3 Suppl):802-12. PubMed ID: 12548579
    [Abstract] [Full Text] [Related]

  • 11. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H.
    J Bone Miner Res; 2001 Nov 01; 16(11):2074-81. PubMed ID: 11697804
    [Abstract] [Full Text] [Related]

  • 12. Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro.
    Chikatsu N, Takeuchi Y, Tamura Y, Fukumoto S, Yano K, Tsuda E, Ogata E, Fujita T.
    Biochem Biophys Res Commun; 2000 Jan 19; 267(2):632-7. PubMed ID: 10631114
    [Abstract] [Full Text] [Related]

  • 13. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H, Guo J, Bringhurst FR.
    J Bone Miner Res; 2002 Sep 19; 17(9):1667-79. PubMed ID: 12211438
    [Abstract] [Full Text] [Related]

  • 14. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
    Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT.
    J Bone Miner Res; 2001 Oct 19; 16(10):1787-94. PubMed ID: 11585342
    [Abstract] [Full Text] [Related]

  • 15. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
    Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA.
    J Bone Miner Res; 2001 Jun 19; 16(6):1004-14. PubMed ID: 11393777
    [Abstract] [Full Text] [Related]

  • 16. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M, Sugimoto T, Kano J, Kanzawa M, Chihara K.
    J Cell Physiol; 2003 Jul 19; 196(1):180-9. PubMed ID: 12767054
    [Abstract] [Full Text] [Related]

  • 17. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation.
    Nagai M, Sato N.
    Biochem Biophys Res Commun; 1999 Apr 21; 257(3):719-23. PubMed ID: 10208850
    [Abstract] [Full Text] [Related]

  • 18. Cytological properties of stromal cells derived from giant cell tumor of bone (GCTSC) which can induce osteoclast formation of human blood monocytes without cell to cell contact.
    Nishimura M, Yuasa K, Mori K, Miyamoto N, Ito M, Tsurudome M, Nishio M, Kawano M, Komada H, Uchida A, Ito Y.
    J Orthop Res; 2005 Sep 21; 23(5):979-87. PubMed ID: 16024207
    [Abstract] [Full Text] [Related]

  • 19. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
    Shalhoub V, Faust J, Boyle WJ, Dunstan CR, Kelley M, Kaufman S, Scully S, Van G, Lacey DL.
    J Cell Biochem; 1999 Feb 01; 72(2):251-61. PubMed ID: 10022507
    [Abstract] [Full Text] [Related]

  • 20. Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
    Nyambo R, Cross N, Lippitt J, Holen I, Bryden G, Hamdy FC, Eaton CL.
    J Bone Miner Res; 2004 Oct 01; 19(10):1712-21. PubMed ID: 15355567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.